1.	Phase III Comparison of Hormonal vs Mechanical Contraception for Reduction of Trophoblastic Sequelae Following Hydatidiform Mole Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-55
2.	Phase III Randomized Trial of Hormone Therapy with TMX vs MEG vs TMX plus MEG in Patients with Advanced Breast Cancer Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NEDH-D-83007, NCI-V85-0130
3.	Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer Phase: Phase II Type: Prevention Status: Closed Age: 25 to 50 Sponsor: NCI, Other Protocol IDs: ID01-340, P30CA016672, MDA-ID-01340, NCI-P02-0218, CDR0000069277, TX035, N01-CN-05127, NCT00033358
4.	Phase II Sequential Treatment with Ethinyl Estradiol and MPA for Metastatic and/or Recurrent Breast Cancer in Postmenopausal Women Phase: Phase II Type: Treatment Status: Completed Age: 75 and under Sponsor: Protocol IDs: PCCC-83239, NCI-V83-0354
5.	Phase II Evaluation of the Effect of Estrogenic Recruitment on Response to FAC Combination Chemotherapy for Advanced Stage III/IV Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: under 71 Sponsor: Protocol IDs: EORTC-10807
6.	Phase II Hormone Manipulation Therapy with Ethinyl Estradiol and MPA for Recurrent Epithelial Ovarian Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: 45 and over Sponsor: Protocol IDs: MDA-G-8006, NCI-V84-0022
7.	Phase II Study of CALF-E (CTX/ADR/CF/5-FU/Ethinyl Estradiol) Induction and Radiotherapy in Patients with Breast Cancer Stages III and IV, Clinical T3N0, and Stage II with Four or More Positive Nodes (Summary Last Modified 08/91) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: GUMC-7589, NCI-V89-0179